2007 World Congress on Huntington`s Disease

The World Congress is a joint meeting of the World
Federation of Neurology
(WFN) Research Group on Huntington`s Disease
(HD) and the International Huntington Association
(IHA). Traditionally,
the WFN Research Group on HD and the IHA met separately every two
years; the Congress in Dresden will be the 22nd Meeting of the WFN
Research Group on HD and the 17th meeting of the IHA. Since the 2003
Congress (Toronto) these meetings have been
restructured and now form a joint meeting which goes under the name of
Congress on Huntington`s Disease (WCHD). The WCHD in 2007 is
organised in association with the clinical, scientific and
patients` organisations concerned with HD.

The congress offers a scientific program open to clinicians, basic
scientists and HD organisations.The scientific programme includes
presentations covering:

  • genetics
  • pathogenesis
  • clinical aspects of HD (neurology,neuropsychology,neuropsychiatry and genetic counselling)
  • neuropathology

  • biomarkers (imaging and biomarkers in body fluids)

  • drug discovery and development
  • clinical trial results

  • the latest therapeutic advances
  • public
  • care and coping strategies

  • education

The congress will therefore be of interest to all researchers and
health professionals concerned with HD, and to members of the HD associations.

International Huntington Association (IHA)

IHA members the World
Congress will start with the Business Meeting on Saturday, September 8,
2007 and will be supplemented by parallel sessions of the IHA
on Monday, September 10, 2007 and Tuesday, September 11, 2007, which will
feature updates, reports and presentations related to the work of the IHA members around the world.